These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 11237213)

  • 1. Cell-specific roles of glucokinase in glucose homeostasis.
    Postic C; Shiota M; Magnuson MA
    Recent Prog Horm Res; 2001; 56():195-217. PubMed ID: 11237213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.
    Postic C; Shiota M; Niswender KD; Jetton TL; Chen Y; Moates JM; Shelton KD; Lindner J; Cherrington AD; Magnuson MA
    J Biol Chem; 1999 Jan; 274(1):305-15. PubMed ID: 9867845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele.
    Rossetti L; Chen W; Hu M; Hawkins M; Barzilai N; Efrat S
    Am J Physiol; 1997 Oct; 273(4):E743-50. PubMed ID: 9357804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis.
    Grupe A; Hultgren B; Ryan A; Ma YH; Bauer M; Stewart TA
    Cell; 1995 Oct; 83(1):69-78. PubMed ID: 7553875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribozyme-mediated attenuation of pancreatic beta-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion.
    Efrat S; Leiser M; Wu YJ; Fusco-DeMane D; Emran OA; Surana M; Jetton TL; Magnuson MA; Weir G; Fleischer N
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2051-5. PubMed ID: 7510884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of glucokinase-MODY mutants to inactivation by oxidative stress in pancreatic β-cells.
    Cullen KS; Matschinsky FM; Agius L; Arden C
    Diabetes; 2011 Dec; 60(12):3175-85. PubMed ID: 22028181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype.
    Miller SP; Anand GR; Karschnia EJ; Bell GI; LaPorte DC; Lange AJ
    Diabetes; 1999 Aug; 48(8):1645-51. PubMed ID: 10426385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose.
    Terauchi Y; Sakura H; Yasuda K; Iwamoto K; Takahashi N; Ito K; Kasai H; Suzuki H; Ueda O; Kamada N
    J Biol Chem; 1995 Dec; 270(51):30253-6. PubMed ID: 8530440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UCP2 mRNA expression is dependent on glucose metabolism in pancreatic islets.
    Dalgaard LT
    Biochem Biophys Res Commun; 2012 Jan; 417(1):495-500. PubMed ID: 22177951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene.
    Bali D; Svetlanov A; Lee HW; Fusco-DeMane D; Leiser M; Li B; Barzilai N; Surana M; Hou H; Fleischer N
    J Biol Chem; 1995 Sep; 270(37):21464-7. PubMed ID: 7665557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI).
    Burke CV; Buettger CW; Davis EA; McClane SJ; Matschinsky FM; Raper SE
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):345-52. PubMed ID: 10455021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice.
    Sreenan SK; Cockburn BN; Baldwin AC; Ostrega DM; Levisetti M; Grupe A; Bell GI; Stewart TA; Roe MW; Polonsky KS
    Diabetes; 1998 Dec; 47(12):1881-8. PubMed ID: 9836519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of MODY2 mutations highlights the importance of the fine-tuning of glucokinase and its role in glucose sensing.
    García-Herrero CM; Rubio-Cabezas O; Azriel S; Gutierrez-Nogués A; Aragonés A; Vincent O; Campos-Barros A; Argente J; Navas MA
    PLoS One; 2012; 7(1):e30518. PubMed ID: 22291974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease.
    Terauchi Y; Iwamoto K; Tamemoto H; Komeda K; Ishii C; Kanazawa Y; Asanuma N; Aizawa T; Akanuma Y; Yasuda K; Kodama T; Tobe K; Yazaki Y; Kadowaki T
    J Clin Invest; 1997 Mar; 99(5):861-6. PubMed ID: 9062343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable effects of maturity-onset-diabetes-of-youth (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme.
    Liang Y; Kesavan P; Wang LQ; Niswender K; Tanizawa Y; Permutt MA; Magnuson MA; Matschinsky FM
    Biochem J; 1995 Jul; 309 ( Pt 1)(Pt 1):167-73. PubMed ID: 7619052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program.
    Inoue M; Sakuraba Y; Motegi H; Kubota N; Toki H; Matsui J; Toyoda Y; Miwa I; Terauchi Y; Kadowaki T; Shigeyama Y; Kasuga M; Adachi T; Fujimoto N; Matsumoto R; Tsuchihashi K; Kagami T; Inoue A; Kaneda H; Ishijima J; Masuya H; Suzuki T; Wakana S; Gondo Y; Minowa O; Shiroishi T; Noda T
    Hum Mol Genet; 2004 Jun; 13(11):1147-57. PubMed ID: 15102714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high-fat diet on glucose homeostasis and gene expression in glucokinase knockout mice.
    Gorman T; Hope DC; Brownlie R; Yu A; Gill D; Löfvenmark J; Wedin M; Mayers RM; Snaith MR; Smith DM
    Diabetes Obes Metab; 2008 Sep; 10(10):885-97. PubMed ID: 18034843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric activators of glucokinase: potential role in diabetes therapy.
    Grimsby J; Sarabu R; Corbett WL; Haynes NE; Bizzarro FT; Coffey JW; Guertin KR; Hilliard DW; Kester RF; Mahaney PE; Marcus L; Qi L; Spence CL; Tengi J; Magnuson MA; Chu CA; Dvorozniak MT; Matschinsky FM; Grippo JF
    Science; 2003 Jul; 301(5631):370-3. PubMed ID: 12869762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism.
    Niswender KD; Shiota M; Postic C; Cherrington AD; Magnuson MA
    J Biol Chem; 1997 Sep; 272(36):22570-5. PubMed ID: 9278411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research.
    Polonsky KS
    Diabetes; 1995 Jun; 44(6):705-17. PubMed ID: 7789637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.